4 Matching Annotations
- Nov 2022
-
-
Neither the developmental nor the validation datasetsincluded patients with mild (GOLD 1) severity and, assuch, we could not establish the accuracy of predictionsfor this subgroup.
Mencionar en nuestros estudios
-
ACCEPT is externally validated in anindependent cohort extending its generalisability beyondtherapeutic clinical trials.
Esto es algo que podríamos hacer en el CSA2
-
Azithromycin reduces annual exacer-bation rate by 27%.8
Azitromicina
-
ACCEPT can combine predicted risk with effectestimates from randomised trials to enable personalisedtreatment.
esto sería interesante recalcar en el ensayo clínico
-